scispace - formally typeset
Y

Yuhai Zhao

Researcher at LSU Health Sciences Center New Orleans

Publications -  92
Citations -  4648

Yuhai Zhao is an academic researcher from LSU Health Sciences Center New Orleans. The author has contributed to research in topics: Gene expression & microRNA. The author has an hindex of 34, co-authored 83 publications receiving 3757 citations. Previous affiliations of Yuhai Zhao include University of Texas Health Science Center at Houston & University of Texas at Austin.

Papers
More filters
Journal ArticleDOI

An NF-κB-sensitive Micro RNA-146a-mediated Inflammatory Circuit in Alzheimer Disease and in Stressed Human Brain Cells

TL;DR: Data indicate that NF-κB-sensitive miRNA-146a-mediated modulation of CFH gene expression may in part regulate an inflammatory response in AD brain and in stressed HN cell models of AD and illustrate the potential for anti-miRNAs as an effective therapeutic strategy against pathogenic inflammatory signaling.
Journal ArticleDOI

Secretory Products of the Human GI Tract Microbiome and Their Potential Impact on Alzheimer's Disease (AD): Detection of Lipopolysaccharide (LPS) in AD Hippocampus.

TL;DR: The presence of bacterial lipopolysaccharide (LPS) in brain lysates from the hippocampus and superior temporal lobe neocortex of Alzheimer's disease (AD) brains is reported for the first time.
Journal ArticleDOI

Deficiency in the Ubiquitin Conjugating Enzyme UBE2A in Alzheimer's Disease (AD) is Linked to Deficits in a Natural Circular miRNA-7 Sponge (circRNA; ciRS-7).

TL;DR: Dysfunction of circRNA-miRNA-mRNA regulatory systems appears to represent another important layer of epigenetic control over pathogenic gene expression programs in the human CNS that are targeted by the sporadic AD process.
Journal ArticleDOI

Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase- and PPARγ-mediated mechanisms in Alzheimer's disease models.

TL;DR: NPD1 bioactivity potently down regulates inflammatory signaling, amyloidogenic APP cleavage and apoptosis, underscoring the potential of this lipid mediator to rescue human brain cells in early stages of neurodegenerations.
Journal Article

microRNA (miRNA) speciation in Alzheimer's disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF)

TL;DR: Analysis of amyloid beta peptide and micro RNA abundance in CSF and brain tissue-derived extracellular fluid from Alzheimer's disease and short post-mortem interval suggest that they may be involved in the modulation or proliferation of miRNA-triggered pathogenic signaling throughout the brain and central nervous system (CNS).